S.C. Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$953K Buy
18,601
+524
+3% +$25.1K 1.47% 14
2022
Q3
$791K Buy
18,077
+27
+0.1% +$1.31K 1.25% 19
2022
Q2
$946K Buy
18,050
+1,167
+7% +$59.5K 1.45% 15
2022
Q1
$874K Sell
16,883
-4,690
-22% -$243K 1.12% 22
2021
Q4
$1.2M Buy
+21,573
New +$1.07M 1.38% 17

Other funds holding PFE

S.C. Financial Services's PFE Position: Q4 2022 in Review

S.C. Financial Services increased its Pfizer (PFE) stake by 2.9% in Q4 2022, buying an estimated $25.1K and bringing the position to 18,601 shares worth $953K. The position accounts for 1.47% of the portfolio, ranked #14.

S.C. Financial Services first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $1.2M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • S.C. Financial Services held 18,601 shares of Pfizer worth $953K as of Q4 2022.
  • S.C. Financial Services bought 524 Pfizer shares in Q4 2022, an estimated $25.1K.
  • Pfizer made up 1.47% of S.C. Financial Services's portfolio in Q4 2022, its #14 holding.
  • S.C. Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • S.C. Financial Services's Pfizer position peaked at $1.2M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on S.C. Financial Services's 13F filing for Q4 2022, filed 20 Jan 2023.